Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Centre Partners" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Centre Partners for you to read. Along with our medical data and news we also list Centre Partners Clinical Trials, which are updated daily. BioPortfolio also has a large database of Centre Partners Companies for you to search.
On Wednesday 23 May 2018, over 1200 scientists, technicians, speakers and exhibitors descended on the East Midlands Conference Centre at the University of Nottingham for the fifth Scientific Laboratory Show and Conference... The post We met. We learnt. We discovered. appeared first on European Pharmaceutical Review.
NewsThe ESCAPE-2 project on energy-efficient scalable algorithms for weather and climate prediction at the exascale was launched at an ECMWF kick-off meeting.Contri
(University of Adelaide) Defining Australian wines' unique flavors, making vines more robust, defeating disease and introducing more innovation to winemaking are among the key goals of a new national center launched at the University of Adelaide's Waite campus today.
(European Centre for Disease Prevention and Control (ECDC) ) Infections with bacteria resistant to carbapenems, a group of highly effective antibiotics, pose a significant threat to patients and healthcare systems in all EU/EEA countries, warns ECDC in a Rapid Risk Assessment.
CORDOBA, Spain - June 25, 2018 (Investorideas.com Newswire) Phytoplant Research S.L. participated in a first-ever pioneering collaborative project to investigate the ability of cannabinoid cannabigerol (CBG), the molecular precursor of 9-tetrahydrocannabinol (9-THC) and cannabidiol (CBD).
Gilead Sciences’ subsidiary Kite has signed a research collaboration and licence agreement with biotechnology company HiFiBiO Therapeutics to help develop...Read More... The post Kite partners with HiFiBiO Therapeutics for TCR-based cancer therapies appeared first on Pharmaceutical Technology.
Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for the treatment of a variety of seizure disorders.
Interviews from the Women deliver conference in Copenhagen. Donna McCarraher, director of reproductive, maternal, newborn and child health at FHI 360, explains why women should be at the centre of efforts to mitigate the effect of Zika Virus in Brazil.
CDRD, The Centre for Drug Research and Development will be honoured with the 2018 BIOTECanada Gold Leaf Ecosystem Builder Award at a special Global Biotech Week event tonight in Ottawa. The award recognizes CDRD’s contributions and impact as Canada’s national life sciences venture, bringing together national and international partners to be a ...
“With regards to IP and patents, Silence will vigorously enforce its patent estate where third parties are considered to be infringing the company's patent rights," said Silence chief executive, Dr David Horn Solomon.
PCI Pharma Services has announced the installation and validation of its latest comprehensive serialisation system at its manufacturing Centre of Excellence in Tredegar, UK.
Kite will support Gadeta in the development of a new type of CAR-T therapy that could be more effective in solid tumors. Approved just last year, CAR-T cell therapy is offering hope to patients with severe forms of blood cancer. ... The post Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy appeared first on Labiotech.eu.
Boehringer Ingelheim says the biologics development facility in Biberach, Germany will support both its research pipeline and contract manufacturing business.
Russell Compact Sieve paired with innovative ultrasonic technology increases throughput and prototype iteration at New Balance
SÖDERTÄLJE, Sweden, Sept.10, 2018 /PRNewswire/ -- Scania will contribute to a new research centre at the Stockholm School of Economics (SSE) over the next ten Read more...
The Uganda Biotechnology Information Centre urged the country's education system to include biosciences. -More-
AELIX Therapeutics and Gilead will run a clinical trial testing a combination of treatments that has potential to let HIV-infected people ditch lifelong therapy. The trial, which will run in Spain, is planned to start in early 2019 and ... The post Spanish Biotech Partners Gilead to Develop Functional HIV Cure appeared first on Labiotech.eu.
(Max Planck Institute for Chemical Ecology) Unicellular diatoms are able to adapt their behavior to different external stimuli based on an evaluation of their own needs. This was discovered by scientists of the Friedrich Schiller University and the Max Planck Institute for Chemical Ecology in Jena, Germany, together with partners from Belgium. In experiments, Seminavis robusta diatoms directed th...
(John Innes Centre) A leading researcher at The Sainsbury Laboratory, Norwich, UK, has been honored with a prestigious international award in recognition of his innovative work on plant immunity.
The Swiss─based Ferring Pharmaceuticals will set up its new research and development laboratory and a manufacturing facility at the Genome Valley of Hyderabad.
(John Innes Centre) A new study has isolated a gene controlling shape and size of spikelets in wheat in a breakthrough which could help breeders deliver yield increases in one of the world's most important crops.
In a study published in Stem Cell Reports, a McGill team of scientists led by Dr. Carl Ernst, researcher at the Douglas Hospital Research Centre, revealed a molecular mechanism that may play a role in the development of autism.
(European Commission Joint Research Centre) Artists lucky enough to find their song on Spotify's most popular playlists could see could see considerable increases in streams and revenue.
A groundbreaking drug, rifampin, could help to end the global tuberculosis epidemic, according to researchers. Clinical trials carried out at the McGill University Health Centre showed that rifampin is less toxic and is more effective than the sta...
Exclusion from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) because of Brexit will have serious consequences for public health in the UK, warn experts.